| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | Dolan Christine | See Remarks | Mar 15, 2024 | Option Exercise | $7.70 | 5,383 | 41,449 | 258,007 | Mar 18, 2024, 05:58 PM | |
| MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | Dolan Christine | See Remarks | Feb 15, 2024 | Option Exercise | $5.48 | 1,941 | 10,637 | 263,390 | Feb 20, 2024, 06:46 PM | |
| MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | Dolan Christine | See Remarks | Oct 31, 2023 | Option Exercise | $5.83 | 1,729 | 10,080 | 75,727 | Nov 16, 2023, 05:21 PM | |
| MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | Dolan Christine | See Remarks | Apr 28, 2023 | Option Exercise | $11.72 | 1,394 | 16,338 | 73,998 | Jul 19, 2023, 04:51 PM | |
| MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | Dolan Christine | See Remarks | Feb 15, 2023 | Option Exercise | $15.23 | 1,956 | 29,790 | 16,829 | Feb 17, 2023, 04:34 PM | |
| MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | Dolan Christine | See Remarks | Apr 29, 2022 | Option Exercise | $22.95 | 666 | 15,285 | 18,785 | Jun 27, 2022, 06:42 PM | |
| MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | Dolan Christine | See Remarks | Apr 30, 2021 | Option Exercise | $22.95 | 916 | 21,022 | 916 | Jan 27, 2022, 04:00 PM | |
| MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | Dolan Christine | See Remarks | Oct 31, 2021 | Option Exercise | $22.95 | 203 | 4,659 | 1,119 | Jan 27, 2022, 04:00 PM | |
| CTLT | Catalent, Inc. | Dolan Christine | SVP - Product Development | Aug 29, 2017 | Option Exercise | $27.70 | 16,708 | 462,788 | 27,007 | Aug 31, 2017, 10:41 AM | |
| CTLT | Catalent, Inc. | Dolan Christine | SVP - Product Development | Aug 24, 2017 | Option Exercise | $35.21 | 1,881 | 66,230 | 17,857 | Aug 28, 2017, 12:26 PM | |
| CTLT | Catalent, Inc. | Dolan Christine | SVP - Product Development | Aug 01, 2017 | Sale | $34.85 | 745 | 25,963 | 14,058 | Aug 03, 2017, 05:31 PM | |
| CTLT | Catalent, Inc. | Dolan Christine | SVP - Product Development | Jul 31, 2017 | Option Exercise | $34.97 | 734 | 25,668 | 14,803 | Aug 01, 2017, 06:33 PM |
Menu